Neutralizing Antibodies in Survivors of Sin Nombre and Andes Hantavirus Infection
We evaluated titers of homotypic and heterotypic neutralizing antibodies (NAbs) to Andes and Sin Nombre hantaviruses in plasma samples from 20 patients from Chile and the United States. All but 1 patient had high titers of NAb. None of the plasma samples showed high titers against the heterologous v...
Main Authors: | Francisca Valdivieso, Pablo Vial, Marcela Ferres, Chunyan Ye, Diane Goade, Analia Cuiza, Brian Hjelle |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2006-01-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/12/1/05-0930_article |
Similar Items
-
Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
by: Chunyan Ye, et al.
Published: (2004-03-01) -
Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses
by: Bryce M Warner, et al.
Published: (2019-07-01) -
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
by: Taylor B. Engdahl, et al.
Published: (2021-05-01) -
Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model
by: James Duehr, et al.
Published: (2020-03-01) -
Biodefense Implications of New-World Hantaviruses
by: Michael Hilary D’Souza, et al.
Published: (2020-08-01)